An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (0)
  • Podcast (1)
  • Publications (58)
  • Training (0)
  • User case (0)
  • User meeting (0)
  • Webinar (3)
  • White paper (0)
Key content topics
Key audience
  • Newcomers (0)
Top cancer treatments
  • Brain and CNS (88)
  • Breast (59)
  • Gastro-intestinal (125)
  • (-) Genito-urinary (51)
  • Gynecological (7)
  • Head and neck (133)
  • Hodgkin and Non-Hodgkin lymphoma (16)
  • (-) Ocular (12)
  • Pediatric (100)
  • Reirradiation (12)
  • Sarcomas (18)
  • Thoracic (91)
  • Reset filters
  • (-) Genito-urinary
  • (-) Ocular

Comparative Analysis of 5-Year Clinical Outcomes and Patterns of Failure of Proton Beam Therapy (PBT) versus Intensity-Modulated Radiotherapy (IMRT) for Prostate Cancer in the Postoperative Setting

10/11/2020
/ Publications
/
IMRT

This case-matched study analyzed 260 prostate cancer patients including 65 treated with PBT and 195 IMRT. At a median follow-up of 59 months, biochemical...

Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma (B/P-RMS).

07/08/2019
/ Publications
/
Toxicity

This study reported outcomes of 19 patients of B/P-RMS treated with PBT. With a median follow-up of 66.2 months, 5-year overall survival (OS) and progression...

Extreme hypofractionated proton radiotherapy for prostate cancer using pencil beam scanning: Dosimetry, acute toxicity and preliminary results.

07/09/2019
/ Publications
/
Hypofractionation
Pencil Beam Scanning - PBS

A study by the research group in Prague. Two hundred patients with early-stage prostate cancer were treated with IMPT on extreme hypofractionated schedule (36...

Comparative toxicity outcomes of PBT vs IMRT for prostate cancer in the postoperative setting.

07/09/2019
/ Publications
/
Toxicity

A case-matched cohort analysis study compared acute and late genitourinary (GU) and gastrointestinal (GI) toxicity outcomes in patients with prostate cancer (PC...

Particle therapy for prostate cancer: past, present and future.

07/07/2019
/ Publications

A review article by the Japanese researchers about the particle radiotherapy in comparison to photon-based radiation for prostate cancer. Due to a lack of...

Early and late side effects, dosimetric parameters and QoL after PBT and IMRT for prostate cancer

03/03/2019
/ Publications
/
Dosimetry

A study by the researchers of Dresden and Heidelberg. Eighty-eight patients with localized prostate cancer treated with PBT (31) or IMRT (57) were matched using...

Patient-Reported Sexual Survivorship Following High-Dose Image-Guided PT for Prostate Cancer.

03/02/2019
/ Publications
/
Imaging System

A study by the Jacksonville group published in the Green Journal aimed to identify baseline predictive factors that impact long-term erectile function. 676...

Four-year outcomes from a prospective phase II clinical trial of moderately hypofractionated PT for localized prostate cancer.

04/06/2019
/ Publications

Published in the Red Journal, the researchers of Upenn and Groningen reported the clinical and patient-reported outcomes for patients with prostate cancer...

Literature Review of PBT for Prostate Cancer in Japan.

01/01/2019
/ Publications

A literature review on published works related to proton beam therapy for prostate cancer in Japan. 23 articles were analyzed including fourteen observational...

LT results of a phase II study of hypofractionated PT for prostate cancer

01/01/2019
/ Publications

A study by the Korean group of National Cancer Center. Eighty-two patients with T1-3bN0M0 prostate cancer were randomized to one of five arms: Arm 1, 60 cobalt...

Pagination

  • Previous page ‹
    • Page 3
    • Current page 4
    • Page 5
  • Next page ›
Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies